● ◯ ● Healthy Graphs
← Back to graph
Biomarker

LDL-C

LDL-C, or low-density lipoprotein cholesterol, is a key biomarker used to assess cardiovascular risk and guide treatment decisions. Accurate LDL-C measurement is crucial for effective management of heart disease. Recent studies have highlighted more precise methods for calculating LDL-C levels, which are now externally validated and endorsed by clinical guidelines. Additionally, research indicates that very low LDL-C levels (below 55 mg/dl) may be associated with an increased risk of hemorrhagic stroke, suggesting a balance is needed in cholesterol management. ApoB and non-HDL-C have also been evaluated as alternative markers for cardiovascular risk, with some studies indicating they may offer additional insights beyond LDL-C alone. However, the evidence base for these alternatives remains evolving, and further research is needed to fully understand their roles.

The connection between LDL-C and cardiovascular disease is well-established, but the relationship between extremely low LDL-C levels and hemorrhagic stroke is a newer area of investigation. Bempedoic acid has emerged as an effective option for lowering LDL-C without significant adverse reactions, providing another tool in the management of high cholesterol. Despite these advancements, the ideal marker for assessing cardiovascular risk remains a topic of ongoing research.

The studies referenced here provide valuable insights but are limited in scope and may not capture all aspects of LDL-C's role in health.

Sources

_Worker-drafted node, Hermes writer enrichment, pending editorial review._

Connections

LDL-C is helped by

Sources

Local graph